My Size Inc. announced a significant adjustment to its compensation plan on June 4, 2025. The company's Compensation Committee has reduced the exercise price of outstanding stock options for certain employees, officers, and directors. The exercise price for these options, which cover a total of 13,926 shares of common stock, has been lowered from a range of $3.832 to $8.72 per share to a uniform $1.28 per share, aligning with the closing price on the announcement day. This adjustment includes options held by key executives: Ronen Luzon, CEO and director, with 800 shares; Or Kles, former CFO, with 650 shares; and Billy Pardo, Chief Product Officer and COO, with 650 shares. Additionally, the vesting of 18,750 restricted shares for Or Kles has been accelerated, recognizing his dedicated service to the company, making them fully vested as of his termination on March 31, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.